Physician profile
Niraj P Gupta
NPI 1073566261
$4,038.37
in general payments reported to CMS, 2019-2025
14 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $376 · 2021: $815 · 2022: $1,137 · 2023: $484 · 2024: $469 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.75 |
| Education | $178.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $1,332.64 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $747.81 | 2019-2023 | Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $379.60 | 2019-2025 | Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $370.15 | 2019-2023 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $347.83 | 2022-2025 | Austedo Xr, Uzedy, Austedo |
| Allergan, INC. | $129.08 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.00 | 2024 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $124.52 | 2024 | Cobenfy |
| Axsome Therapeutics, INC. | $121.08 | 2023 | Auvelity |
| Indivior INC. | $112.03 | 2019-2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $83.99 | 2019-2022 | |
| Focal Therapeutics, INC. | $79.54 | 2019 | |
| Neurocrine Biosciences, INC. | $57.00 | 2021-2024 | Ingrezza |
| Sumitomo Pharma America, INC. | $28.10 | 2023 | Latuda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.